Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

机译：非典型溶血性尿毒症综合征（aHUS）中维持剂量的依库丽单抗降低：以前病例报告的更新

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

ObjectiveTo describe how maintenance eculizumab sustains improved renal function in severe atypical hemolytic uremic syndrome (aHUS).

机译：目的描述维持依库丽单抗如何在严重的非典型溶血性尿毒症综合征（aHUS）中维持改善的肾功能。

著录项

期刊名称 Clinical Pharmacology : Advances and Applications
作者
Maro Ohanian; Christian Cable; Kathleen Halka;
展开▼
作者单位

展开▼
年(卷),期 2011(3),-1
年度 2011
页码 45–50
总页数 6
原文格式 PDF
正文语种
中图分类药学;
关键词
eculizumab aHUS thrombotic microangiopathy atypical hemolytic uremic syndrome;

机译：依库丽单抗;aHUS;血栓性微血管病;非典型溶血性尿毒症综合征;

相似文献

外文文献
中文文献
专利

1. Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report [J] . Maro Ohanian, Christian Cable, Kathleen Halka Clinical Pharmacology: Advances and Applications . 2011,第6期

机译：非典型溶血性尿毒症综合征（aHUS）的维持剂量依库丽单抗降低：先前病例报告的更新
2. ATYPICAL HEMOLYTIC UREMIC SYNDROME (aHUS): ONE-YEAR UPDATE ON THE INHIBITION OF THROMBOTIC MICROANGIOPATHY (TMA) AND IMPROVED RENAL FUNCTION (RF) IN PEDIATRIC PATIENTS TREATED WITH ECULIZUMAB [J] . Kincaid J. F., Greenbaum L. A., Fila M., Pediatric nephrology: journal of the International Pediatric Nephrology Association . 2015,第12期

机译：非典型溶血性尿毒症综合征（aHUS）：厄库珠单抗治疗小儿血栓性微血管病（TMA）和改善的肾功能（RF）一年更新
3. Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature [J] . Saitovitch David, Carolina Araujo Rodrigues, Deise de Boni Monteiro de Carvalho, Clinical Case Reports . 2016,第8期

机译：维持依库丽单抗剂量调整治疗非典型溶血性尿毒症综合征：一例病例并文献复习
4. Clinical validation of vaccines against hemolytic uremic syndrome [C] . Selvam M. Masilamani, Sasitharan Divya, Paul W. Manohar 2014 International Conference on Science Engineering and Management Research . 2014

机译：溶血性尿毒症综合征疫苗的临床验证
5. Bacterial factors contributing to the pathogenesis of the hemolytic uremic syndrome. [D] . Edwards, Kelly Katherine. 2002

机译：导致溶血性尿毒症综合征发病机理的细菌因素。
6. Maintenance eculizumab dose adjustment in the treatment of atypical hemolytic uremic syndrome: a case report and review of the literature [O] . Nick Thomson, Matthew Ulrickson 2016

机译：维持依库丽单抗剂量调整治疗非典型溶血性尿毒症综合征：一例病例并文献复习
7. Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report [O] . Ohanian, Maro, Cable, Christian, Halka, Kathleen 2011

机译：非典型溶血性尿毒症综合征（aHUS）的依库丽单抗维持剂量降低：先前病例报告的更新

Reduced dose maintenance eculizumab in atypical hemolytic uremic syndrome (aHUS): an update on a previous case report

摘要

著录项

相似文献

相关主题

期刊订阅